Recent Progress in Work on PGD2 Antagonists for Drugs Targeting Allergic Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|28|3533-3538

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.28, 2004-11, pp. : 3533-3538

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent progress in 5-HT6 receptor antagonists for the treatment of CNS diseases

By Slassi Abdelmalik   Isaac Methvin   O’Brien Anne  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 4, 2002-04 ,pp. : 513-527

Informa Healthcare

Access to resources Recommend Favorite

Recent progress in the discovery of antagonists acting at P2X7 receptor

By Romagnoli Romeo   Baraldi Pier Giovanni   Di Virgilio Francesco  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 3, 2005-03 ,pp. : 271-287

Informa Healthcare

Access to resources Recommend Favorite

Recent Progress and Future Potential for Metal Complexes as Anticancer Drugs Targeting G-quadruplex DNA

By  

Current Medicinal Chemistry, Vol. 19, Iss. 18, 2012-06 ,pp. : 2957-2975

Bentham Science Publishers

Access to resources Recommend Favorite

Metabolic considerations of drugs in the treatment of allergic diseases

By García-Martín Elena   Canto Gabriela   Agúndez José AG  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 11, 2013-11 ,pp. : 1437-1452

Informa Healthcare

Access to resources Recommend Favorite

Recent Progress in the Development of Agonists and Antagonists for Melatonin Receptors

By  

Current Medicinal Chemistry, Vol. 19, Iss. 21, 2012-07 ,pp. : 3532-3549

Bentham Science Publishers

Access to resources Recommend Favorite